Finding a new biomarker and drug target in breast cancer
Consumer Health: Treating encephalitis
21 February 2022Early life treatment prevents autism symptoms from developing in mice
21 February 2022Finding a new biomarker and drug target in breast cancer
After examining 398 proteins, a University of Houston College of Pharmacy researcher has found one that is an important biomarker predicting therapy outcome and a potential drug target in estrogen receptor-positive (ER+) breast cancer, which makes up approximately 80% of all breast cancers. The growth of ER+ breast cancer is stimulated by estrogen.
